Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; Department of Gastroenterology, Sapienza University of Rome, Rome, Italy.
Medical-Surgical and Biotechnologies Sciences, Polo Pontino, Sapienza University of Rome, Latina, Italy.
ESMO Open. 2022 Feb;7(1):100377. doi: 10.1016/j.esmoop.2021.100377. Epub 2022 Jan 27.
Cholangiocarcinomas (CCAs) are a rare group of malignancies characterized by dismal prognosis. There are currently no standardized guidelines for multidisciplinary teams (MDTs) in CCAs.
An online survey was built with the aim of defining the current practice of MDTs in CCAs and identifying possible areas of improvement, providing minimum standards of practice for an ideal CCA MDT. Analysis of the replies regarding current and ideal MDT practice was carried out by calculating weighted average (WA) of likelihood of every item. The survey was shared with members of the European Network for the Study of Cholangiocarcinoma and other medical centers with expertise in biliary tract cancer part of the EURO-CHOLANGIO-NET (European Cholangiocarcinoma Network: https://eurocholangionet.eu/) COST Action CA18122 initiative.
The role of the MDT coordinator was a recognized priority in an ideal well-functioning MDT (WA 3.31/4), together with providing minimum clinical information before the meeting to secure adequate case preparation (WA 3.54/4). Optimal frequency of MDT meetings was weekly according to 76.92% of the participants; 73.06% believed that ideally all newly diagnosed patients and each new treatment should be discussed, although that happened only in less than half of the MDTs (46.15%) in current practice. Most participants stated that they always (46.15%) or often (50.00%) used guidelines, mainly international (61.00%) (European and American), followed by national/local (39.00%). We defined the ideal setup of a CCA MDT, identifying specialists whose presence is mandatory with WA >3.0 (oncologist, clinician responsible for patient's care, surgeon, diagnostic and interventional radiologist, hepatologist, pathologist, endoscopist and gastroenterologist) and those whose presence would be recommended with a WA <3.0 (palliative care, nurse, dietitian, basic researcher, psychologist and social worker).
Our identified minimum requirements should be taken into account at the time of CCA MDT setup and quality assessment.
胆管癌(CCA)是一组罕见的恶性肿瘤,预后不良。目前,多学科团队(MDT)在 CCA 中尚无标准化指南。
我们建立了一个在线调查,旨在确定 CCA 中 MDT 的当前实践,并确定可能的改进领域,为理想的 CCA MDT 提供实践的最低标准。通过计算每个项目的可能性加权平均值(WA),对当前和理想 MDT 实践的回复进行分析。该调查与欧洲胆管癌研究网络的成员以及具有胆道癌专业知识的其他医疗中心共享,这些医疗中心是 EURO-CHOLANGIO-NET(欧洲胆管癌网络:https://eurocholangionet.eu/)COST 行动 CA18122 倡议的一部分。
MDT 协调员的角色是功能良好的理想 MDT 的优先事项(WA 3.31/4),并在会议前提供最低限度的临床信息,以确保充分的病例准备(WA 3.54/4)。根据 76.92%的参与者,最佳 MDT 会议频率是每周;73.06%的人认为理想情况下应讨论所有新诊断的患者和每种新的治疗方法,但这仅在当前实践中不到一半的 MDT 中发生(46.15%)。大多数参与者表示,他们始终(46.15%)或经常(50.00%)使用指南,主要是国际指南(61.00%)(欧洲和美国),其次是国家/地区指南(39.00%)。我们确定了 CCA MDT 的理想设置,确定了存在必要性的专家(WA >3.0,包括肿瘤学家、负责患者护理的临床医生、外科医生、诊断和介入放射科医生、肝病专家、病理学家、内镜专家和胃肠病学家)和推荐存在的专家(WA <3.0,包括姑息治疗专家、护士、营养师、基础研究人员、心理学家和社会工作者)。
在建立和评估 CCA MDT 时,应考虑我们确定的最低要求。